Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinomaDavid V Gold, Zarir Karanjawala, David E Modrak, et al.
Cancer Research|November 19, 2004
Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancerDavid E Modrak, Thomas M Cardillo, Guy A Newsome, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2012
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumabXiaochuan Chen, Chien-Hsing Chang, Rhona Stein, et al.
International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.
Plos One|February 14, 2013
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathologyDavid M Goldenberg, David V Gold, Meiyu Loo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.
Molecular Cancer Therapeutics|February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancersSerengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
International Journal of Clinical and Experimental Pathology|November 15, 2013
Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinomaSabrina C Sopha, Purva Gopal, Nipun B Merchant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
CD74 is expressed by multiple myeloma and is a promising target for therapyJack D Burton, Scott Ely, Praveen K Reddy, et al.
Cancer|August 18, 2012
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinomaDavid V Gold, Jochen Gaedcke, B Michael Ghadimi, et al.
Pageof 3